The API provides a wide range of detailed disease information, facilitating access to key data for medical analysis and applications. From specific related genes to genetic variants and associated phenotypes, this API becomes an invaluable tool for understanding and addressing various medical conditions.
At its core, the API provides access to comprehensive disease data, enabling the querying of information such as genes linked to a particular disease, genetic variants identified in association with the condition, and relevant clinical phenotypes. This information is essential for researchers studying the genetic basis of diseases, as it provides detailed insight into how certain genes and their variants may influence predisposition to or development of a specific disease.
A highlight of the API is its ability to easily integrate with existing applications and systems in healthcare and biomedical research. This allows developers to create custom tools that use the API data to improve the diagnosis, treatment and understanding of complex diseases.
In short, the API not only provides access to detailed and accurate data on diseases, genes and genetic variants, but also stands out for its ability to support scientific research, medical innovation and continuous improvement of evidence-based healthcare. Its versatility and robustness make it an essential tool in the arsenal of any practitioner or researcher seeking to understand and address the complexities of disease from an advanced genomic and clinical perspective.
It will receive a parameter and provide you with a JSON.
Besides the number of API calls, there is no other limitation.
To use this endpoint you must indicate the name of a disease in the parameter.
Disease - Características del Endpoint
| Objeto | Descripción |
|---|---|
q |
[Requerido] |
{"took":16,"total":724,"max_score":7.9725885,"hits":[{"_id":"MONDO:0011361","_score":7.9725885,"ctd":{"omim":"603688","pathway_related_to_disease":[{"inference_gene_symbol":"EPHB2","kegg_pathway_id":"hsa04360","pathway_name":"Axon guidance","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"Developmental Biology","react_pathway_id":"R-HSA-1266738","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"EPH-Ephrin signaling","react_pathway_id":"R-HSA-2682334","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"L1CAM interactions","react_pathway_id":"R-HSA-373760","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"EPHB-mediated forward signaling","react_pathway_id":"R-HSA-3928662","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"Ephrin signaling","react_pathway_id":"R-HSA-3928664","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"EPH-ephrin mediated repulsion of cells","react_pathway_id":"R-HSA-3928665","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"Axon guidance","react_pathway_id":"R-HSA-422475","source":"CTD"}]},"disgenet":{"_license":"https://creativecommons.org/licenses/by/4.0/","genes_related_to_disease":[{"DPI":0.846,"DSI":0.374,"gene_id":2048,"gene_name":"EPHB2","score":0.4,"source":"CLINVAR"},{"DPI":0.846,"DSI":0.374,"gene_id":2048,"gene_name":"EPHB2","score":0.4,"source":"CTD_human"}],"variants_related_to_disease":[{"DSI":1.0,"chrom":"1","pos":22907980,"rsid":"rs121912582","score":0.7,"source":"CLINVAR"},{"DPI":0.08,"DSI":0.882,"chrom":"1","pos":22913757,"rsid":"rs76826147","score":0.7,"source":"CLINVAR"}],"xrefs":{"disease_name":"PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY (finding)","mondo":"MONDO:0011361","omim":"603688","umls":"C1863600"}},"hpo":{"disease_name":"Prostate cancer/brain cancer susceptibility","omim":"603688","phenotype_related_to_disease":[{"biocuration":{"date":"2013-01-14","name":"HPO:skoehler"},"evidence":"IEA","hpo_id":"HP:0100006","omim_refs":"OMIM:603688","original_disease_id":"OMIM:603688"},{"biocuration":{"date":"2013-01-09","name":"HPO:skoehler"},"evidence":"IEA","hpo_id":"HP:0012125","omim_refs":"OMIM:603688","original_disease_id":"OMIM:603688"}]},"mondo":{"ancestors":["MONDO:0003847","MONDO:0020573","MONDO:0023370","MONDO:0021058","MONDO:0700096","MONDO:0002254","MONDO:0045024","MONDO:0042489","MONDO:0015356","MONDO:0000001"],"excluded_subClassOf":{"mondo":["MONDO:0008315"]},"has_material_basis_in_germline_mutation_in":{"http":["http://identifiers.org/hgnc/3393"]},"label":"prostate cancer/brain cancer susceptibility","mondo":"MONDO:0011361","parents":["MONDO:0015356"],"predisposes_towards":{"mondo":["MONDO:0001657"]},"synonym":{"exact":["prostate cancer/brain cancer susceptibility","prostate cancer/brain cancer susceptibility, somatic"],"related":["Capb","Pcbc"]},"xrefs":{"medgen":["400334"],"omim":["603688"],"umls":["C1863600"]}}},{"_id":"MONDO:0018502","_score":7.36427,"mondo":{"ancestors":["MONDO:0005070","MONDO:0021223","MONDO:0700096","MONDO:0001056","MONDO:0004992","MONDO:0021085","MONDO:0005626","MONDO:0003847","MONDO:0004335","MONDO:0045024","MONDO:0002516","MONDO:0004950","MONDO:0004993","MONDO:0023370","MONDO:0004298","MONDO:0000001","MONDO:0006181"],"children":["MONDO:0006226","MONDO:0007648","MONDO:0017790","MONDO:0100256"],"definition":"Hereditary gastric cancer refers to the occurrence of gastric cancer in a familial context and is described as two or more cases of gastric cancer in first or second degree relatives with at least one case diagnosed before the age of 50. Familial clustering is observed in 10% of all cases of gastric cancer, and includes hereditary diffuse gastric cancer (early onset diffuse-type gastric cancer), gastric adenocarcinoma and proximal polyposis of the stomach and familial intestinal gastric cancer (familial clustering of intestinal type gastric adenocarcinoma). Hereditary gastric cancer can also occur in other hereditary cancer syndromes such as Lynch syndrome, Li-Fraumeni syndrome, familial adenomatous polyposis and juvenile polyposis syndrome. [Orphanet:423776]","descendants":["MONDO:0100256","MONDO:0017790","MONDO:0007648","MONDO:0006226"],"label":"hereditary gastric cancer","mondo":"MONDO:0018502","parents":["MONDO:0003847","MONDO:0004950"],"synonym":{"exact":["hereditary cancer of stomach","hereditary gastric cancer"]},"xrefs":{"gard":["21758"],"medgen":["1843054"],"orphanet":["423776"],"umls":["C5680075"]}}},{"_id":"MONDO:0001060","_score":7.269791,"disease_ontology":{"_license":"https://github.com/DiseaseOntology/HumanDiseaseOntology/blob/master/DO_LICENSE.txt","ancestors":["DOID:14566","DOID:5517","DOID:305","DOID:3119","DOID:0050686","DOID:10534","DOID:4","DOID:76","DOID:77","DOID:7","DOID:0050687","DOID:162","DOID:3717","DOID:299"],"children":[],"def":"","descendants":[],"doid":"DOID:10541","name":"microinvasive gastric cancer","parents":["DOID:3717"],"synonyms":{"exact":["early gastric cancer","Surface gastric cancer"]},"xrefs":{"ncit":"C27131","snomedct_us_2023_03_01":"276809004","umls_cui":"C0349530"}},"disgenet":{"_license":"https://creativecommons.org/licenses/by/4.0/","genes_related_to_disease":[{"DPI":0.885,"DSI":0.429,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":174,"gene_name":"AFP","pubmed":[29121872],"score":0.01,"source":"BEFREE"},{"DPI":0.962,"DSI":0.373,"EI":1.0,"YearFinal":2016,"YearInitial":2014,"gene_id":324,"gene_name":"APC","pubmed":[27514024,24272205],"score":0.02,"source":"BEFREE"},{"DPI":0.808,"DSI":0.502,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":387,"gene_name":"RHOA","pubmed":[28624843],"score":0.01,"source":"BEFREE"},{"DPI":0.923,"DSI":0.344,"EI":1.0,"YearFinal":2014,"YearInitial":2014,"gene_id":595,"gene_name":"CCND1","pubmed":[25202078],"score":0.01,"source":"BEFREE"},{"DPI":0.423,"DSI":0.666,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":618,"gene_name":"BCYRN1","pubmed":[29039538],"score":0.01,"source":"BEFREE"},{"DPI":0.731,"DSI":0.459,"EI":1.0,"YearFinal":2008,"YearInitial":2008,"gene_id":864,"gene_name":"RUNX3","pubmed":[18097595],"score":0.01,"source":"BEFREE"},{"DPI":0.962,"DSI":0.363,"EI":1.0,"YearFinal":2019,"YearInitial":2016,"gene_id":960,"gene_name":"CD44","pubmed":[27923017,30913874,25779358],"score":0.03,"source":"BEFREE"},{"DPI":0.808,"DSI":0.401,"EI":1.0,"YearFinal":2010,"YearInitial":2010,"gene_id":999,"gene_name":"CDH1","pubmed":[20063069],"score":0.01,"source":"BEFREE"},{"DPI":0.769,"DSI":0.458,"EI":1.0,"YearFinal":2019,"YearInitial":2019,"gene_id":1045,"gene_name":"CDX2","pubmed":[31354341],"score":0.01,"source":"BEFREE"},{"DPI":0.846,"DSI":0.42,"EI":1.0,"YearFinal":2018,"YearInitial":2017,"gene_id":1048,"gene_name":"CEACAM5","pubmed":[29121872,29742692],"score":0.02,"source":"BEFREE"},{"DPI":0.731,"DSI":0.494,"EI":1.0,"YearFinal":2018,"YearInitial":2017,"gene_id":1084,"gene_name":"CEACAM3","pubmed":[29121872,29742692],"score":0.02,"source":"BEFREE"},{"DPI":0.769,"DSI":0.494,"EI":1.0,"YearFinal":2018,"YearInitial":2017,"gene_id":1087,"gene_name":"CEACAM7","pubmed":[29121872,29742692],"score":0.02,"source":"BEFREE"},{"DPI":0.808,"DSI":0.446,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":1268,"gene_name":"CNR1","pubmed":[27271924],"score":0.01,"source":"BEFREE"},{"DPI":0.846,"DSI":0.4,"EI":1.0,"YearFinal":2018,"YearInitial":2018,"gene_id":1351,"gene_name":"COX8A","pubmed":[30128004],"score":0.01,"source":"BEFREE"},{"DPI":0.615,"DSI":0.558,"EI":1.0,"YearFinal":2012,"YearInitial":2012,"gene_id":1365,"gene_name":"CLDN3","pubmed":[22290341],"score":0.01,"source":"BEFREE"},{"DPI":0.808,"DSI":0.494,"EI":1.0,"YearFinal":2012,"YearInitial":2012,"gene_id":1366,"gene_name":"CLDN7","pubmed":[22290341],"score":0.01,"source":"BEFREE"},{"DPI":0.846,"DSI":0.488,"EI":1.0,"YearFinal":2018,"YearInitial":2018,"gene_id":1371,"gene_name":"CPOX","pubmed":[29425880],"score":0.01,"source":"BEFREE"},{"DPI":0.923,"DSI":0.328,"EI":1.0,"YearFinal":2005,"YearInitial":2005,"gene_id":1636,"gene_name":"ACE","pubmed":[16365022],"score":0.01,"source":"BEFREE"},{"DPI":0.885,"DSI":0.426,"EI":1.0,"YearFinal":2019,"YearInitial":2019,"gene_id":1666,"gene_name":"DECR1","pubmed":[31370714],"score":0.01,"source":"BEFREE"},{"DPI":0.885,"DSI":0.295,"EI":1.0,"YearFinal":2015,"YearInitial":2015,"gene_id":1956,"gene_name":"EGFR","pubmed":[25593477],"score":0.01,"source":"BEFREE"},{"DPI":0.923,"DSI":0.328,"EI":1.0,"YearFinal":2018,"YearInitial":2015,"gene_id":2064,"gene_name":"ERBB2","pubmed":[30120594,25593477],"score":0.02,"source":"BEFREE"},{"DPI":0.615,"DSI":0.656,"EI":1.0,"YearFinal":2019,"YearInitial":2017,"gene_id":2098,"gene_name":"ESD","pubmed":[31382963,30725253,28378078,30298447],"score":0.04,"source":"BEFREE"},{"DPI":0.692,"DSI":0.588,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":2168,"gene_name":"FABP1","pubmed":[27884752],"score":0.01,"source":"BEFREE"},{"DPI":0.846,"DSI":0.474,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":2194,"gene_name":"FASN","pubmed":[27884752],"score":0.01,"source":"BEFREE"},{"DPI":0.808,"DSI":0.485,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":2520,"gene_name":"GAST","pubmed":[28072871],"score":0.01,"source":"BEFREE"},{"DPI":0.808,"DSI":0.489,"EI":1.0,"YearFinal":2019,"YearInitial":2019,"gene_id":2744,"gene_name":"GLS","pubmed":[30485682],"score":0.01,"source":"BEFREE"},{"DPI":0.577,"DSI":0.686,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":3004,"gene_name":"GZMM","pubmed":[28977792],"score":0.01,"source":"BEFREE"},{"DPI":0.885,"DSI":0.374,"EI":1.0,"YearFinal":2017,"YearInitial":2017,"gene_id":3082,"gene_name":"HGF","pubmed":[28595915],"score":0.01,"source":"BEFREE"},{"DPI":0.769,"DSI":0.476,"EI":1.0,"YearFinal":2015,"YearInitial":2015,"gene_id":3490,"gene_name":"IGFBP7","pubmed":[26043748],"score":0.01,"source":"BEFREE"},{"DPI":0.923,"DSI":0.373,"EI":1.0,"YearFinal":2004,"YearInitial":2004,"gene_id":3557,"gene_name":"IL1RN","pubmed":[15570075],"score":0.01,"source":"BEFREE"},{"DPI":0.962,"DSI":0.248,"EI":1.0,"YearFin...
curl --location --request GET 'https://zylalabs.com/api/4424/diseases+information+api/5437/disease?q=cancer' --header 'Authorization: Bearer YOUR_API_KEY'
To use this endpoint you must specify a Mondo ID in the parameter.
For example: MONDO:0011361
You will get this ID from the Disease endpoint.
{"_id":"MONDO:0011361","_version":1,"ctd":{"omim":"603688","pathway_related_to_disease":[{"inference_gene_symbol":"EPHB2","kegg_pathway_id":"hsa04360","pathway_name":"Axon guidance","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"Developmental Biology","react_pathway_id":"R-HSA-1266738","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"EPH-Ephrin signaling","react_pathway_id":"R-HSA-2682334","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"L1CAM interactions","react_pathway_id":"R-HSA-373760","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"EPHB-mediated forward signaling","react_pathway_id":"R-HSA-3928662","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"Ephrin signaling","react_pathway_id":"R-HSA-3928664","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"EPH-ephrin mediated repulsion of cells","react_pathway_id":"R-HSA-3928665","source":"CTD"},{"inference_gene_symbol":"EPHB2","pathway_name":"Axon guidance","react_pathway_id":"R-HSA-422475","source":"CTD"}]},"disgenet":{"_license":"https://creativecommons.org/licenses/by/4.0/","genes_related_to_disease":[{"DPI":0.846,"DSI":0.374,"gene_id":2048,"gene_name":"EPHB2","score":0.4,"source":"CLINVAR"},{"DPI":0.846,"DSI":0.374,"gene_id":2048,"gene_name":"EPHB2","score":0.4,"source":"CTD_human"}],"variants_related_to_disease":[{"DSI":1.0,"chrom":"1","pos":22907980,"rsid":"rs121912582","score":0.7,"source":"CLINVAR"},{"DPI":0.08,"DSI":0.882,"chrom":"1","pos":22913757,"rsid":"rs76826147","score":0.7,"source":"CLINVAR"}],"xrefs":{"disease_name":"PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY (finding)","mondo":"MONDO:0011361","omim":"603688","umls":"C1863600"}},"hpo":{"disease_name":"Prostate cancer/brain cancer susceptibility","omim":"603688","phenotype_related_to_disease":[{"biocuration":{"date":"2013-01-14","name":"HPO:skoehler"},"evidence":"IEA","hpo_id":"HP:0100006","omim_refs":"OMIM:603688","original_disease_id":"OMIM:603688"},{"biocuration":{"date":"2013-01-09","name":"HPO:skoehler"},"evidence":"IEA","hpo_id":"HP:0012125","omim_refs":"OMIM:603688","original_disease_id":"OMIM:603688"}]},"mondo":{"ancestors":["MONDO:0003847","MONDO:0020573","MONDO:0023370","MONDO:0021058","MONDO:0700096","MONDO:0002254","MONDO:0045024","MONDO:0042489","MONDO:0015356","MONDO:0000001"],"excluded_subClassOf":{"mondo":["MONDO:0008315"]},"has_material_basis_in_germline_mutation_in":{"http":["http://identifiers.org/hgnc/3393"]},"label":"prostate cancer/brain cancer susceptibility","mondo":"MONDO:0011361","parents":["MONDO:0015356"],"predisposes_towards":{"mondo":["MONDO:0001657"]},"synonym":{"exact":["prostate cancer/brain cancer susceptibility","prostate cancer/brain cancer susceptibility, somatic"],"related":["Capb","Pcbc"]},"xrefs":{"medgen":["400334"],"omim":["603688"],"umls":["C1863600"]}}}
curl --location --request GET 'https://zylalabs.com/api/4424/diseases+information+api/5439/disease+by+id&ID=Required' --header 'Authorization: Bearer YOUR_API_KEY'
| Encabezado | Descripción |
|---|---|
Autorización
|
[Requerido] Debería ser Bearer access_key. Consulta "Tu Clave de Acceso a la API" arriba cuando estés suscrito. |
Sin compromiso a largo plazo. Mejora, reduce o cancela en cualquier momento. La Prueba Gratuita incluye hasta 50 solicitudes.
Diseases Information API provides structured data and information on various diseases, including genetic factors, associated genes, clinical manifestations and related pathways.
Zyla provides a wide range of integration methods for almost all programming languages. You can use these codes to integrate with your project as you need.
There are different plans to suit all tastes, including a free trial for a small number of requests, but your rate is limited to avoid abuse of the service.
This API is essential because it allows users to obtain detailed and up-to-date information on a wide range of diseases, including genetic data, associated genes, variants, clinical data and relevant pathways.
To use this API, users must indicate the name of a disease.
The GET Disease endpoint returns a list of diseases with associated genes, genetic variants, and clinical phenotypes. The GET Disease by ID endpoint provides detailed information about a specific disease, including pathways related to the disease and gene interactions.
Key fields include "_id" (disease identifier), "ctd" (data related to genes and pathways), "omim" (Online Mendelian Inheritance in Man ID), and "pathway_related_to_disease" (list of pathways linked to the disease).
The response data is structured in JSON format, with a top-level object containing metadata (like "took" and "total") and an array of "hits" that detail each disease's information, including associated genes and pathways.
The GET Disease endpoint provides disease names, associated genes, and genetic variants. The GET Disease by ID endpoint offers in-depth details about a specific disease, including pathways, gene interactions, and clinical data.
The GET Disease endpoint requires the disease name as a parameter, while the GET Disease by ID endpoint requires a specific Mondo ID. These parameters allow users to customize their queries for targeted information.
Users can analyze the returned data to identify genetic factors associated with diseases, support clinical decision-making, and inform research on disease mechanisms. The structured format allows for easy integration into applications.
The data is sourced from reputable biomedical databases, including the Comparative Toxicogenomics Database (CTD) and Online Mendelian Inheritance in Man (OMIM), ensuring high accuracy and reliability.
If the API returns partial or empty results, users should verify the input parameters for accuracy. Additionally, consider using broader search terms or checking for alternative disease names to improve result retrieval.
Zyla API Hub es como una gran tienda de APIs, donde puedes encontrar miles de ellas en un solo lugar. También ofrecemos soporte dedicado y monitoreo en tiempo real de todas las APIs. Una vez que te registres, puedes elegir qué APIs quieres usar. Solo recuerda que cada API necesita su propia suscripción. Pero si te suscribes a varias, usarás la misma clave para todas, lo que hace todo más fácil para ti.
Los precios se muestran en USD (dólar estadounidense), EUR (euro), CAD (dólar canadiense), AUD (dólar australiano) y GBP (libra esterlina). Aceptamos todas las principales tarjetas de débito y crédito. Nuestro sistema de pago utiliza la última tecnología de seguridad y está respaldado por Stripe, una de las compañías de pago más confiables del mundo. Si tienes algún problema para pagar con tarjeta, contáctanos en [email protected]
Además, si ya tienes una suscripción activa en cualquiera de estas monedas (USD, EUR, CAD, AUD, GBP), esa moneda se mantendrá para suscripciones posteriores. Puedes cambiar la moneda en cualquier momento siempre que no tengas suscripciones activas.
La moneda local que aparece en la página de precios se basa en el país de tu dirección IP y se proporciona solo como referencia. Los precios reales están en USD (dólar estadounidense). Cuando realices un pago, el cargo aparecerá en tu estado de cuenta en USD, incluso si ves el monto equivalente en tu moneda local en nuestro sitio web. Esto significa que no puedes pagar directamente en tu moneda local.
Ocasionalmente, un banco puede rechazar el cargo debido a sus configuraciones de protección contra fraude. Te sugerimos comunicarte con tu banco primero para verificar si están bloqueando nuestros cargos. También puedes acceder al Portal de Facturación y cambiar la tarjeta asociada para realizar el pago. Si esto no funciona y necesitas más ayuda, por favor contacta a nuestro equipo en [email protected]
Los precios se determinan mediante una suscripción recurrente mensual o anual, dependiendo del plan elegido.
Las llamadas a la API se descuentan de tu plan en base a solicitudes exitosas. Cada plan incluye una cantidad específica de llamadas que puedes realizar por mes. Solo las llamadas exitosas, indicadas por una respuesta con estado 200, se contarán en tu total. Esto asegura que las solicitudes fallidas o incompletas no afecten tu cuota mensual.
Zyla API Hub funciona con un sistema de suscripción mensual recurrente. Tu ciclo de facturación comenzará el día en que compres uno de los planes de pago, y se renovará el mismo día del mes siguiente. Así que recuerda cancelar tu suscripción antes si quieres evitar futuros cargos.
Para actualizar tu plan de suscripción actual, simplemente ve a la página de precios de la API y selecciona el plan al que deseas actualizarte. La actualización será instantánea, permitiéndote disfrutar inmediatamente de las funciones del nuevo plan. Ten en cuenta que las llamadas restantes de tu plan anterior no se transferirán al nuevo plan, por lo que debes considerar esto al actualizar. Se te cobrará el monto total del nuevo plan.
Para verificar cuántas llamadas a la API te quedan en el mes actual, revisa el campo 'X-Zyla-API-Calls-Monthly-Remaining' en el encabezado de la respuesta. Por ejemplo, si tu plan permite 1,000 solicitudes por mes y has usado 100, este campo mostrará 900 llamadas restantes.
Para ver el número máximo de solicitudes a la API que permite tu plan, revisa el encabezado de la respuesta 'X-Zyla-RateLimit-Limit'. Por ejemplo, si tu plan incluye 1,000 solicitudes por mes, este encabezado mostrará 1,000.
El encabezado 'X-Zyla-RateLimit-Reset' muestra el número de segundos hasta que tu límite se restablezca. Esto te indica cuándo tu conteo de solicitudes se reiniciará. Por ejemplo, si muestra 3,600, significa que faltan 3,600 segundos para que el límite se restablezca.
Sí, puedes cancelar tu plan en cualquier momento desde tu cuenta, seleccionando la opción de cancelación en la página de Facturación. Ten en cuenta que las actualizaciones, degradaciones y cancelaciones tienen efecto inmediato. Además, al cancelar ya no tendrás acceso al servicio, incluso si te quedaban llamadas en tu cuota.
Puedes contactarnos a través de nuestro canal de chat para recibir asistencia inmediata. Siempre estamos en línea de 8 a. m. a 5 p. m. (EST). Si nos contactas fuera de ese horario, te responderemos lo antes posible. Además, puedes escribirnos por correo electrónico a [email protected]
Para darte la oportunidad de probar nuestras APIs sin compromiso, ofrecemos una prueba gratuita de 7 días que te permite realizar hasta 50 llamadas a la API sin costo. Esta prueba solo se puede usar una vez, por lo que recomendamos aplicarla a la API que más te interese. Aunque la mayoría de nuestras APIs ofrecen prueba gratuita, algunas pueden no hacerlo. La prueba finaliza después de 7 días o cuando realices 50 solicitudes, lo que ocurra primero. Si alcanzas el límite de 50 solicitudes durante la prueba, deberás "Iniciar tu Plan de Pago" para continuar haciendo solicitudes. Puedes encontrar el botón "Iniciar tu Plan de Pago" en tu perfil bajo Suscripción -> Elige la API a la que estás suscrito -> Pestaña de Precios. Alternativamente, si no cancelas tu suscripción antes del día 7, tu prueba gratuita finalizará y tu plan se cobrará automáticamente, otorgándote acceso a todas las llamadas a la API especificadas en tu plan. Ten esto en cuenta para evitar cargos no deseados.
Después de 7 días, se te cobrará el monto total del plan al que estabas suscrito durante la prueba. Por lo tanto, es importante cancelar antes de que finalice el periodo de prueba. No se aceptan solicitudes de reembolso por olvidar cancelar a tiempo.
Cuando te suscribes a una prueba gratuita de una API, puedes realizar hasta 50 llamadas. Si deseas realizar más llamadas después de este límite, la API te pedirá que "Inicies tu Plan de Pago". Puedes encontrar el botón "Iniciar tu Plan de Pago" en tu perfil bajo Suscripción -> Elige la API a la que estás suscrito -> Pestaña de Precios.
Las Órdenes de Pago se procesan entre el día 20 y el 30 de cada mes. Si envías tu solicitud antes del día 20, tu pago será procesado dentro de ese período.
Nivel de Servicio:
100%
Tiempo de Respuesta:
2.015ms
Nivel de Servicio:
100%
Tiempo de Respuesta:
2.015ms
Nivel de Servicio:
100%
Tiempo de Respuesta:
1.036ms
Nivel de Servicio:
100%
Tiempo de Respuesta:
1.809ms
Nivel de Servicio:
100%
Tiempo de Respuesta:
0ms
Nivel de Servicio:
100%
Tiempo de Respuesta:
1.988ms
Nivel de Servicio:
100%
Tiempo de Respuesta:
1.499ms
Nivel de Servicio:
100%
Tiempo de Respuesta:
458ms
Nivel de Servicio:
100%
Tiempo de Respuesta:
597ms
Nivel de Servicio:
100%
Tiempo de Respuesta:
453ms
Nivel de Servicio:
100%
Tiempo de Respuesta:
0ms
Nivel de Servicio:
100%
Tiempo de Respuesta:
384ms
Nivel de Servicio:
100%
Tiempo de Respuesta:
1.520ms
Nivel de Servicio:
100%
Tiempo de Respuesta:
0ms
Nivel de Servicio:
100%
Tiempo de Respuesta:
904ms
Nivel de Servicio:
100%
Tiempo de Respuesta:
5.909ms
Nivel de Servicio:
100%
Tiempo de Respuesta:
3.003ms
Nivel de Servicio:
100%
Tiempo de Respuesta:
1.538ms
Nivel de Servicio:
100%
Tiempo de Respuesta:
1.079ms
Nivel de Servicio:
100%
Tiempo de Respuesta:
609ms
Registro gratuito
